Picture of Clover Health Investments logo

CLOV Clover Health Investments News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Clover Health Investments Corp expected to post a loss of 18 cents a share - Earnings Preview

* Clover Health Investments Corp  CLOV.OQ   CLOV.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 9. 
    * The Franklin Tennessee-based  company is expected to
report  a
43.0% decrease in revenue to $498.738 million from $874.38
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 18 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.4​, above​ its last closing price
of $0.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.23       -0.26      -0.17     Beat    31.4
 Sep. 30 2022  -0.25       -0.24      -0.16     Beat    33.1
 Jun. 30 2022  -0.21       -0.21      -0.22     Missed  -6.7​
 Mar. 31 2022  -0.28       -0.27      -0.19     Beat    30.5
 ​​Dec.        -0.27       -0.26      -0.28     Missed  -7.9
 31 2021                                                
 Sep. 30 2021  -0.24       -0.23      -0.08     Beat    65​
 Jun. 30 2021  -0.13       -0.14      -0.78     Missed  -476.4
 Mar. 31 2021  -0.11       -0.11      -0.13     Missed  -17.5
 This summary was machine generated May 6 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Clover Health Investments

See all news